Nutrition
Volume 24, Issue 4 , Pages 300-304 , April 2008

Influence of Ala54Thr polymorphism of fatty acid–binding protein-2 on clinical results of biliopancreatic diversion

  • Daniel A. de Luis, M.D.

      Affiliations

    • Institute of Endocrinology and Nutrition, Medical School, University of Valladolid, Valladolid, Spain
    • Unit of Investigation, Surgical and Endocrinology Departments, Hospital Rio Hortega, University of Valladolid, Valladolid, Spain
    • Corresponding Author InformationCorresponding author. Tel.: +3498-342-0400; fax: +3498-315-3366.
    • ,
  • Manuel González Sagrado, M.D.

      Affiliations

    • Institute of Endocrinology and Nutrition, Medical School, University of Valladolid, Valladolid, Spain
    • Unit of Investigation, Surgical and Endocrinology Departments, Hospital Rio Hortega, University of Valladolid, Valladolid, Spain
    • ,
  • Olatz Izaola, Ph.D.

      Affiliations

    • Institute of Endocrinology and Nutrition, Medical School, University of Valladolid, Valladolid, Spain
    • Unit of Investigation, Surgical and Endocrinology Departments, Hospital Rio Hortega, University of Valladolid, Valladolid, Spain
    • ,
  • Maria Concepcion Terroba, Ph.D.

      Affiliations

    • Institute of Endocrinology and Nutrition, Medical School, University of Valladolid, Valladolid, Spain
    • ,
  • Luis Cuellar, M.D.

      Affiliations

    • Institute of Endocrinology and Nutrition, Medical School, University of Valladolid, Valladolid, Spain
    • ,
  • Rosa Conde, M.D.

      Affiliations

    • Institute of Endocrinology and Nutrition, Medical School, University of Valladolid, Valladolid, Spain
    • Unit of Investigation, Surgical and Endocrinology Departments, Hospital Rio Hortega, University of Valladolid, Valladolid, Spain
    • ,
  • Tomas Martin, Ph.D.

      Affiliations

    • Institute of Endocrinology and Nutrition, Medical School, University of Valladolid, Valladolid, Spain

Received 25 May 2007 ,Accepted 13 December 2007.

References 

  1. Aranceta J, Perez Rodrigo C, Serra Majem L. Prevalencia de la obesidad en España: estudio SEEDO 97. Med Clin (Barc). 1998;111:441–445
  2. de Luis DA, Aller R, Izaola O, Pacheco D. Early clinical and surgical results of biliopancreatic diversion. Obes Surg. 2005;15:799–802
  3. Scopinaro N, Adami GF, Marinari GM. Biliopancreatic diversión. World J Surg. 1998;22:936–946
  4. Scopinaro N, Giannetta E, Adami GF. Biliopancreatic diversion for obesity at eighteen years. Surgery. 1996;119:261–268
  5. Besnard P. Cellular and molecular aspects of fat metabolism in the small intestine. Proc Nutr Soc. 1996;5:19–37
  6. Van Nieuwenhoven FA, Var der Vusse GJ, Glatz JFC. Membrane associated and cytoplasmatic fatty acid binding proteins. Lipids. 1996;30:s223–s227
  7. Ockner RK, Manning JA. Fatty acid binding protein in small intestine: identification, isolation and evidence for its role in cellular fatty acid binding transport. J Clin Invest. 1974;54:326–328
  8. Baier LJ, Sacchettini JC, Knowler WC. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest. 1995;95:1281–1287
  9. Albala C, Santos JL, Villaroel AC, Lera L, Liberman C. Intestinal FABP2 A54T polymorphism: association with insulin resistance and obesity in women. Obes Res. 2004;12:340–345
  10. de Luis DA, Aller R, Izaola O, Conde R, Gonzalez M. Modulation of the response to a lyfestile modification in obese patients by ala54thr polymorfism of the fatty acid–binding protein 2 gene. Ann Nutr Metab. 2006;50:354–360
  11. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2487
  12. American Diabetes Association. Standards of diabetes mellitus. Diabetes Care. 2007;30:s4–S41
  13. Lukaski H, Johson PE. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr. 1985;41:810–817
  14. Brolin RE, Kanler HA, Gorman RC. The dilemma of outcome assessment after operations for morbid obesity. Surgery. 1983;3:337–346
  15. Kral JG, Branson R, Piec G. Melanocortin-4 receptor gene variants affect results of gastric banding. J Gastrointest Surg. 2004;126(2):A774
  16. Kral JG, Lentes KU, Horber FF. Binge eating as a phenotype of melanocortin 4 receptor gene mutations. N Engl J Med. 2003;349:606–609
  17. Sesti G, Perego L, Cardellini M, Andreozzi F, Ricasoli C, Vedani P, et al. Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet. J Clin Endocrinol Metab. 2005;90:5064–5069
  18. Poitou C, Lacorte JM, Coupaye M, Bertaris S, Bedel JF, Lafon N, et al. Relationship between single nucleotide polymorphisms in leptin, IL6 and adiponectin genes and their circulating product in morbidly obese subjects before and after gastric banding surgery. Obesity Surg. 2005;15:11–23

PII: S0899-9007(07)00386-3

doi: 10.1016/j.nut.2007.12.009

Nutrition
Volume 24, Issue 4 , Pages 300-304 , April 2008

Article Tools